Clinical Trial Finder

Chronic Inflammatory Rheumatism: Management of Comorbidities in Ambulatory Medicine

Study Purpose

Identification of factors limiting compliance with the recommendations established during the evaluation of the SCORIC population by the rheumatology department of the CHU Grenoble Alpes

Recruitment Criteria

Accepts Healthy Volunteers

Healthy volunteers are participants who do not have a disease or condition, or related conditions or symptoms

 No
Study Type

An interventional clinical study is where participants are assigned to receive one or more interventions (or no intervention) so that researchers can evaluate the effects of the interventions on biomedical or health-related outcomes.


An observational clinical study is where participants identified as belonging to study groups are assessed for biomedical or health outcomes.


Searching Both is inclusive of interventional and observational studies.

 Observational
Eligible Ages 18 Years - 90 Years
Gender All
More Inclusion & Exclusion Criteria

Inclusion Criteria:

  • - Patient cohort : - men and women over 18 years of age.
  • - Informed volunteers who have consented to participate in the study.
  • - have rheumatoid arthritis, spondyloarthritis or psoriatic arthritis.
  • - have been hospitalised in a day hospital in the rheumatology department of the Grenoble-Alpes University = SCORIC cohort of the department.
  • - Cohort of referring physicians : - volunteers who received informed information and consented to participate in the study.
  • - be the referring physician of a patient of the SCORIC cohort of the rheumatology department of the South Hospital of the CHU Grenoble-Alpes.

Exclusion Criteria:

  • - Patient cohort : - psychiatric pathologies or history of behavioural disorders.
  • - persons referred to in articles L1121-5 to L1121-8 of the Public Health Code.
  • - persons under guardianship or curatorship.
  • - not affiliated to the social security system.
  • - minors.
  • - Refusal to participate by the patient and/or unreturned questionnaire.
  • - Cohort of referring physicians: - the physician is no longer the patient's referring physician.
- refusal of the doctor to participate and/or questionnaire not returned

Trial Details

Trial ID:

This trial id was obtained from ClinicalTrials.gov, a service of the U.S. National Institutes of Health, providing information on publicly and privately supported clinical studies of human participants with locations in all 50 States and in 196 countries.

 NCT05613712
Phase

Phase 1: Studies that emphasize safety and how the drug is metabolized and excreted in humans.

Phase 2: Studies that gather preliminary data on effectiveness (whether the drug works in people who have a certain disease or condition) and additional safety data.

Phase 3: Studies that gather more information about safety and effectiveness by studying different populations and different dosages and by using the drug in combination with other drugs.

Phase 4: Studies occurring after FDA has approved a drug for marketing, efficacy, or optimal use.
Lead Sponsor

The sponsor is the organization or person who oversees the clinical study and is responsible for analyzing the study data.

 University Hospital, Grenoble
Principal Investigator

The person who is responsible for the scientific and technical direction of the entire clinical study.

 Xavier ROMAND, PHD
Principal Investigator Affiliation CHU Grenoble Alpes
Agency Class

Category of organization(s) involved as sponsor (and collaborator) supporting the trial.

 Other
Overall Status Recruiting
Countries France
Conditions

The disease, disorder, syndrome, illness, or injury that is being studied.

 Chronic Inflammatory Disease
Additional Details

In the rheumatology department of the CHU Grenoble Alpes, Professor Baillet and other rheumatologists have set up a holistic assessment of inflammatory rheumatism (rheumatoid arthritis, spondyloarthritis and psoriatic arthritis) and associated co-morbidities in a day hospital. Based on this assessment, a hospital report is drawn up summarising the patient's treatment options, which is then sent to the patient's referring physician. They analysed the first 100 patients in the cohort and showed that 98% of patients were not up to date with their care. Their longitudinal analysis shows that patients update two thirds of the recommendations made within 12 to 18 months. Therefore, the investigators would like to assess the applicability of this screening in these patients, through a questionnaire sent to the 400 patients of the cohort and to their treating physicians.

Arms & Interventions

Arms

: Patients

Patients followed by the rheumatology department of the CHU Grenoble Alpes, constituting the SCORIC group

: Referring physician

Physicians identified as the referring physician for patients in the SCORIC group

Interventions

Other: - Patients

Description by the patients through the questionnaire of the elements limiting the good ambulatory follow-up

Other: - Referring physician

Description by the referring physicians through the questionnaire of the elements limiting the applicability of the recommendations issued by the rheumatology department of the CHU Grenoble Alpes

Contact a Trial Team

If you are interested in learning more about this trial, find the trial site nearest to your location and contact the site coordinator via email or phone. We also strongly recommend that you consult with your healthcare provider about the trials that may interest you and refer to our terms of service below.

International Sites

CHU Grenoble Alpes, Grenoble, France

Status

Recruiting

Address

CHU Grenoble Alpes

Grenoble, , 38043

Site Contact

Xavier ROMAND, Phd

xromand@chu-grenoble.fr

0476769291

Powered By

The content provided on clinical trials is for informational purposes only and is not a substitute for medical consultation with your healthcare provider. We do not recommend or endorse any specific study and you are advised to discuss the information shown with your healthcare provider. While we believe the information presented on this website to be accurate at the time of writing, we do not guarantee that its contents are correct, complete, or applicable to any particular individual situation. We strongly encourage individuals to seek out appropriate medical advice and treatment from their physicians. We cannot guarantee the availability of any clinical trial listed and will not be responsible if you are considered ineligible to participate in a given clinical trial. We are also not liable for any injury arising as a result of participation.